Please wait while the formulary information is being retrieved.
UVADEX (METHOXSALEN)
- Cutaneous t-cell lymphoma
20 mcg/mL injection solution
- Dosage information is not available
- natalizumab
- Tysabri
Contraindicated
- None
Severe
Moderate
- None
- Albinism
- Aphakia
- Erythropoietic protoporphyria
- Hydroa vacciniforme
- Lactating mother
- Malignant melanoma
- Porphyria
- Porphyria cutanea tarda
- Skin photosensitivity
- Squamous cell carcinoma
- Systemic lupus erythematosus
- Variegate porphyria
- Xeroderma pigmentosum
Contraindicated
- Basal cell carcinoma of skin
- Cataracts
- Disease of liver
- Pregnancy
Severe
Moderate
- None
UVADEX (METHOXSALEN)
- Cutaneous t-cell lymphoma
- None
- None
More Frequent
Severe
Less Severe
- None
- Erythema
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Cardiac arrhythmia
- Cataracts
- Hypotension
- Thromboembolic disorder
Less Severe
- Dysgeusia
- Fever
- Injection site sequelae
- Nausea
- Skin rash
Contraindicated
None
Severe Precaution
Methoxsalen
Safety and efficacy not established in children. Potential risks of carcinogenicity and cataract development with long term use.
- 1 Day – 13 Years
- Safety and efficacy not established in children. Potential risks of carcinogenicity and cataract development with long term use.
Management or Monitoring Precaution
None
Methoxsalen (inj)
- Severity Level:
D
- Additional Notes: Insufficient human data; fetal toxicity in animals at 4000 x single human dose
Contraindicated
Methoxsalen(inj)
Breastfeeding not recommended due to potential risk to infant
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Breastfeeding not recommended due to potential risk to infant |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Cutaneous t-cell lymphoma | |
C84.0 | Mycosis fungoides |
C84.00 | Mycosis fungoides, unspecified site |
C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
C84.07 | Mycosis fungoides, spleen |
C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
C84.09 | Mycosis fungoides, extranodal and solid organ sites |
C84.1 | Sezary disease |
C84.10 | Sezary disease, unspecified site |
C84.11 | Sezary disease, lymph nodes of head, face, and neck |
C84.12 | Sezary disease, intrathoracic lymph nodes |
C84.13 | Sezary disease, intra-abdominal lymph nodes |
C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
C84.16 | Sezary disease, intrapelvic lymph nodes |
C84.17 | Sezary disease, spleen |
C84.18 | Sezary disease, lymph nodes of multiple sites |
C84.19 | Sezary disease, extranodal and solid organ sites |
C84.A | Cutaneous t-cell lymphoma, unspecified |
C84.A0 | Cutaneous t-cell lymphoma, unspecified, unspecified site |
C84.A1 | Cutaneous t-cell lymphoma, unspecified lymph nodes of head, face, and neck |
C84.A2 | Cutaneous t-cell lymphoma, unspecified, intrathoracic lymph nodes |
C84.A3 | Cutaneous t-cell lymphoma, unspecified, intra-abdominal lymph nodes |
C84.A4 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
C84.A5 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
C84.A6 | Cutaneous t-cell lymphoma, unspecified, intrapelvic lymph nodes |
C84.A7 | Cutaneous t-cell lymphoma, unspecified, spleen |
C84.A8 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of multiple sites |
C84.A9 | Cutaneous t-cell lymphoma, unspecified, extranodal and solid organ sites |
C86.6 | Primary cutaneous Cd30-positive t-cell proliferations |
0-9 | A-Z |
---|---|
C84.0 | Mycosis fungoides |
C84.00 | Mycosis fungoides, unspecified site |
C84.01 | Mycosis fungoides, lymph nodes of head, face, and neck |
C84.02 | Mycosis fungoides, intrathoracic lymph nodes |
C84.03 | Mycosis fungoides, intra-abdominal lymph nodes |
C84.04 | Mycosis fungoides, lymph nodes of axilla and upper limb |
C84.05 | Mycosis fungoides, lymph nodes of inguinal region and lower limb |
C84.06 | Mycosis fungoides, intrapelvic lymph nodes |
C84.07 | Mycosis fungoides, spleen |
C84.08 | Mycosis fungoides, lymph nodes of multiple sites |
C84.09 | Mycosis fungoides, extranodal and solid organ sites |
C84.1 | Sezary disease |
C84.10 | Sezary disease, unspecified site |
C84.11 | Sezary disease, lymph nodes of head, face, and neck |
C84.12 | Sezary disease, intrathoracic lymph nodes |
C84.13 | Sezary disease, intra-abdominal lymph nodes |
C84.14 | Sezary disease, lymph nodes of axilla and upper limb |
C84.15 | Sezary disease, lymph nodes of inguinal region and lower limb |
C84.16 | Sezary disease, intrapelvic lymph nodes |
C84.17 | Sezary disease, spleen |
C84.18 | Sezary disease, lymph nodes of multiple sites |
C84.19 | Sezary disease, extranodal and solid organ sites |
C84.A | Cutaneous t-cell lymphoma, unspecified |
C84.A0 | Cutaneous t-cell lymphoma, unspecified, unspecified site |
C84.A1 | Cutaneous t-cell lymphoma, unspecified lymph nodes of head, face, and neck |
C84.A2 | Cutaneous t-cell lymphoma, unspecified, intrathoracic lymph nodes |
C84.A3 | Cutaneous t-cell lymphoma, unspecified, intra-abdominal lymph nodes |
C84.A4 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of axilla and upper limb |
C84.A5 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of inguinal region and lower limb |
C84.A6 | Cutaneous t-cell lymphoma, unspecified, intrapelvic lymph nodes |
C84.A7 | Cutaneous t-cell lymphoma, unspecified, spleen |
C84.A8 | Cutaneous t-cell lymphoma, unspecified, lymph nodes of multiple sites |
C84.A9 | Cutaneous t-cell lymphoma, unspecified, extranodal and solid organ sites |
C86.6 | Primary cutaneous Cd30-positive t-cell proliferations |
Formulary Reference Tool